OLVIG
BHVN icon

Oliver Lagore Vanvalin Investment Group’s Biohaven BHVN Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-202
Closed -$10.1K – 690
2024
Q3 		$10.1K Buy
+202
New +$7.86K ﹤0.01% 424
2024
Q2 		– Sell
-62
Closed -$3.39K – 739
2024
Q1 		$3.39K Sell
62
-38
-38% -$1.88K ﹤0.01% 566
2023
Q4 		$4.28K Buy
+100
New +$3.11K ﹤0.01% 548

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's BHVN Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Biohaven (BHVN) in Q4 2024, closing a stake of 202 shares — an estimated $10.1K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in BHVN in Q4 2023 and held it in 3 quarters. The position peaked at $10.1K in Q3 2024. 256 funds tracked by Wall St. Rank hold BHVN as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Biohaven position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 202 Biohaven shares in Q4 2024, an estimated $10.1K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Biohaven in Q4 2023 and held it in 3 quarters.
  • Oliver Lagore Vanvalin Investment Group's Biohaven position peaked at $10.1K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Biohaven as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.